/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Sex-specific differences in risk stratification of ventricular arrhythmias among implantable cardioverter defibrillator patients: do women differ from men?
Event: ESC Congress 2020
Topic: Risk Factors and Risk Assessment
Session: Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters
Incomplete coronary revascularization increases the risk of ventricular arrhythmias in secondary prevention implantable cardioverter defibrillator patients with coronary artery disease
Event: EHRA 2019
Topic: Risk Factors and Risk Assessment
Session: Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
Prophylactic implantable cardioverter defibrillator implantation in heart failure patients with a reduced ejection fraction: does New York Heart Association class really matter?
Event: EHRA 2019
Topic: Risk Factors and Risk Assessment
Session: Moderated ePosters 12: Challenges in clinical rhythm management
Patients in New York Heart Association functional class I might benefit from primary prevention implantable cardioverter defibrillator therapy
Event: EHRA 2018
Topic: Device Treatment of Ventricular Arrhythmias and SCD
Session: Ventricular arrhythmias and sudden cardiac death (clinical aspects)
Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)
Session: Sudden cardiac death and implantable defibrillators
